Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects
Clinical trial NCT03220633 · COMPLETED
Trial details
- NCT number
- NCT03220633
- Sponsor
- Antibe Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.